Literature DB >> 11333330

Identifying the origin of single corneal cells by DNA fingerprinting: part II-- application to limbal allografting.

T R Henderson1, I Findlay, P L Matthews, B A Noble.   

Abstract

PURPOSE: Successful limbal allotransplantation allows regression of limbal stem cell deficiency features. Transplant survival is presumed if clinical improvement occurs. However, positive proof of surviving transplanted stem cells remains difficult. This follow-up study attempted to prove donor cell survival 5 years after limbal stem cell allograft in one woman with aniridia.
METHODS: Impression cytology and single-cell DNA fingerprinting were used to investigate a previously studied patient. Corneal epithelial cells were harvested from five sites and isolated by micromanipulation. Polymerase chain reaction and short tandem repeat profiling were used to obtain forensic standard "DNA fingerprints" from single cells. (The technique is described in the preceding article, Part I.) Blood samples yielded host and donor DNA for comparison. Negative controls were performed for impression cytology and polymerase chain reaction. Simultaneous micro-scrape samples were also taken.
RESULTS: Impression cytology samples permitted informative DNA fingerprints from all corneal sites and represented 76% (23/30) of tested cells. Fifty percent (15/30) of the fingerprints were "specific" but 83% (19/23) matched the host DNA fingerprint. The remaining 17% (4/23) represented contamination from various sources. Specific fingerprints were obtained in 55% (10/18) of the cells from micro-scrape samples. All samples giving sufficient information matched the host DNA fingerprint. All tested blood samples gave specific fingerprints. None of the sampled corneal cells gave a donor DNA fingerprint.
CONCLUSIONS: In a single patient, no detectable long-term donor cell survival exists at 5 years. Positive identification would have provided unequivocal proof of donor cell survival. This technique gives useful information even if contamination occurs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11333330     DOI: 10.1097/00003226-200105000-00014

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  8 in total

Review 1.  Corneal epithelial stem cells in health and disease.

Authors:  Julie T Daniels; Anna R Harris; Chris Mason
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

2.  Late Acute Rejection After Allograft Limbal Stem Cell Transplantation: Evidence for Long-Term Donor Survival.

Authors:  Medi Eslani; Zeeshan Haq; Asadolah Movahedan; Adam Moss; Alireza Baradaran-Rafii; Gautham Mogilishetty; Edward J Holland; Ali R Djalilian
Journal:  Cornea       Date:  2017-01       Impact factor: 2.651

3.  Existence of Normal Limbal Epithelium in Eyes With Clinical Signs of Total Limbal Stem Cell Deficiency.

Authors:  Eric Chan; Qihua Le; Andres Codriansky; Jiaxu Hong; Jianjian Xu; Sophie X Deng
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

Review 4.  Concise review: limbal stem cell deficiency, dysfunction, and distress.

Authors:  Sajjad Ahmad
Journal:  Stem Cells Transl Med       Date:  2012-01-26       Impact factor: 6.940

Review 5.  Limbal Stem Cell Transplantation: Clinical Results, Limits, and Perspectives.

Authors:  Marta Sacchetti; Paolo Rama; Alice Bruscolini; Alessandro Lambiase
Journal:  Stem Cells Int       Date:  2018-10-11       Impact factor: 5.443

Review 6.  Regenerative Medicine of Epithelia: Lessons From the Past and Future Goals.

Authors:  Eleonora Maurizi; Davide Adamo; Federica Maria Magrelli; Giulia Galaverni; Eustachio Attico; Alessia Merra; Maria Benedetta Rizzarda Maffezzoni; Lorena Losi; Vincenzo Giuseppe Genna; Virginia Sceberras; Graziella Pellegrini
Journal:  Front Bioeng Biotechnol       Date:  2021-03-25

Review 7.  Ex vivo cultivated oral mucosal epithelial cell transplantation for limbal stem cell deficiency: a review.

Authors:  Joao Victor Cabral; Catherine Joan Jackson; Tor Paaske Utheim; Katerina Jirsova
Journal:  Stem Cell Res Ther       Date:  2020-07-21       Impact factor: 6.832

8.  Allogeneic Ex Vivo Expanded Corneal Epithelial Stem Cell Transplantation: A Randomized Controlled Clinical Trial.

Authors:  John D M Campbell; Sajjad Ahmad; Ashish Agrawal; Carol Bienek; Anne Atkinson; Neil W A Mcgowan; Stephen Kaye; Sanjay Mantry; Kanna Ramaesh; Alison Glover; Jane Pelly; Coral MacRury; Margaret MacDonald; Emily Hargreaves; Jacqueline Barry; John Drain; Bruce Cuthbertson; Louis Nerurkar; Ian Downing; Alasdair R Fraser; Marc L Turner; Baljean Dhillon
Journal:  Stem Cells Transl Med       Date:  2019-01-28       Impact factor: 6.940

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.